This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) shed 0.61% to $147.62 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 2.08% to 3,748.57 and Dow Jones Industrial Average falling 1.95% to 32,513.94. The stock's fall snapped a three-day winning streak. AbbVie Inc. closed $28.29 below its 52-week high ($175.91), which the company reached on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Pfizer Inc. (PFE) fell 1.33% to $46.72, Eli Lilly & Co. (LLY) fell 0.92% to $363.27, and AstraZeneca PLC ADR (AZN.LN) fell 0.46% to $61.05. Trading volume (4.5 M) remained 1.1 million below its 50-day average volume of 5.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 9, 2022.
(END) Dow Jones Newswires
November 09, 2022 16:32 ET (21:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.